M59-adjuvanted vaccine against H5N1 influenza antigenic in volunteers

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1293, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted; Prepandrix™): a guide to its use as an active immunization against influenza A subtype H5N1 virus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 3, 2009-03 ,pp. : 5-9

Adis International

Access to resources Recommend Favorite

Adjuvanted H5N1 influenza vaccine offers good safety profile

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Adding MF59 adjuvant to a subvirion H5N1 influenza A virus vaccine appears to increase immunogenicity

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

HAd-H5HA vaccine protects against H5N1 influenza in mice

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

An influenza A H5N1 virus vaccine elicits a protective response, even without an adjuvant and against divergent H5N1 strains

By  

Inpharma, Vol. 1, Iss. 1582, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite